Andrew Q. Viet

机构：Bristol-Myers Squibb (Germany)

发表论文 18 篇 · 总被引 456 次 · h-index 9

代表论文

• Development of Dihydropyridone Indazole Amides as Selective Rho-Kinase Inhibitors (2006 · Journal of Medicinal Chemistry · 被引 157)
• Potent, Selective and Orally Bioavailable Dihydropyrimidine Inhibitors of Rho Kinase (ROCK1) as Potential Therapeutic Agents for Cardiovascular Diseases (2008 · Journal of Medicinal Chemistry · 被引 72)
• Discovery of Aminofurazan-azabenzimidazoles as Inhibitors of Rho-Kinase with High Kinase Selectivity and Antihypertensive Activity (2006 · Journal of Medicinal Chemistry · 被引 72)
• Triazolopyrimidines identified as reversible myeloperoxidase inhibitors (2017 · MedChemComm · 被引 30)
• Potent Triazolopyridine Myeloperoxidase Inhibitors (2018 · ACS Medicinal Chemistry Letters · 被引 28)
• Discovery and structure activity relationships of 7-benzyl triazolopyridines as stable, selective, and reversible inhibitors of myeloperoxidase (2020 · Bioorganic & Medicinal Chemistry · 被引 26)